wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35190641-3F827042-1951-47B9-B4A4-E347077AE615
Q35190641-3F827042-1951-47B9-B4A4-E347077AE615
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35190641-3F827042-1951-47B9-B4A4-E347077AE615
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia
P2860
Q35190641-3F827042-1951-47B9-B4A4-E347077AE615
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35190641-3F827042-1951-47B9-B4A4-E347077AE615
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77e2fd0c7547ce82e12a7c27023727706e4b87d6
P2860
Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines